RSSLetters to the Editor

The Michael Jackson and Winnie Harlow Effect: Impact on Vitiligo Awareness on the Internet

The Michael Jackson and Winnie Harlow Effect: Impact on Vitiligo Awareness on the Internet

| September 1, 2019

Dear Editor: Public awareness of diseases has been shown to increased when celebrities publicly disclose their own.1–3 Hugh Jackman’s public disclosure of his basal cell carcinoma diagnoses via social media is an example in dermatology.4 Here, we evaluated current trends on vitiligo, with emphasis on two celebrities with the condition: the late “King of Pop,” […]

Continue Reading

One-suture Eyelid Margin Repair: How Is It Done?

One-suture Eyelid Margin Repair: How Is It Done?

| September 1, 2019

Dear Editor: Eyelid margin defects are produced by injuries, burns, bites, scars, and benign and malignant lesions. In most cases, adjoining tissues are involved, which require flaps and/or tissue grafts carried out by a skilled surgeon (Figures 1 and 2). The eyelid comprises three layers: the anterior layer is composed of skin and the obicularis […]

Continue Reading

Regarding recently published article on Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for Treatment of Actinic Keratosis

Regarding recently published article on Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for Treatment of Actinic Keratosis

| August 1, 2019

Dear Editor: In their article, “Safety and efficacy of aminolevulinic acid 10% topical gel versus aminolevulinic acid 20% topical solution followed by blue-light photodynamic therapy for the treatment of actinic keratosis on the face and scalp: A randomized, double-blind study,” Nestor et al assessed the response of actinic keratosis (AK) lesions in two 25-cm2 areas […]

Continue Reading

Green Nail Infection by Stenotrophomonas Maltophila

Green Nail Infection by Stenotrophomonas Maltophila

| August 1, 2019

Dear Editor: Stenotrophomonas maltophila (S. maltophila) is a Gram-negative bacterium present in most aquatic and humid environments and in soil and plants. This free-living organism exhibits a high degree of resistance to antibiotics and usually goes undetected in routine cultures. S. maltophila is responsible for a range of infections, including respiratory tract infections, bacteremia, endocarditis, […]

Continue Reading

Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

| June 1, 2019

Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. An increasing number of studies have demonstrated the efficacy of tofacitinib in treatment of alopecia areata (AA).1–6 Treatment duration in these studies […]

Continue Reading

Geographic Tongue Induced by Venetoclax in a Patient with Chronic Lymphocytic Leukemia

Geographic Tongue Induced by Venetoclax in a Patient with Chronic Lymphocytic Leukemia

| May 1, 2019

by Andrew J. Krispinsky, MD; Polina V. Rzepka, MD; Farrukh Awan, MD; and Benjamin H. Kaffenberger, MD Drs. Krispinsky, Rzepka, and Kaffenberger are with the Division of Dermatology and Dr. Awan is with the Division of Hematology­— all from the Department of Internal Medicine at The Ohio State University Comprehensive Cancer Center in Columbus, Ohio. Funding/disclosures. Dr. Awan […]

Continue Reading

Recurrence of Localized Pemphigus Foliaceus Induced by Knee Replacement

Recurrence of Localized Pemphigus Foliaceus Induced by Knee Replacement

| May 1, 2019

J Clin Aesthet Dermatol. 2019;12(5):11–18 by Nima Milani-Nejad MD, PhD; Catherine Chung, MD; and Jessica Kaffenberger, MD All authors are with the Division of Dermatology in the Department of Internal Medicine at The Ohio State University Wexner Medical Center in Columbus, Ohio.  Funding/disclosures. Dr. Kaffenberger is a principal investigator for AbbVie, AnaptysBio, Bristol-Myers, Cara Therapeutics, Celgene, Corrona, Eli […]

Continue Reading